Verification evidence is still being completed.
PDF / print export
ExpreS2ion Biotechnologies
Horsholm, Denmark
- Verified lead
- Bent U. Frandsen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Protein Expression, Vaccine Development, Biotech R&D, and Antigen Production Platforms
- Review cycle
- May 2026
- Full address
- Agern Alle 1, 2970 Horsholm, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official ExpreS2ion contact page confirming the Horsholm address.
- Editorial note
- ExpreS2ion is published because official and investor-facing company materials confirm current leadership, Horsholm operating address, and a real protein-expression biotech platform.
Protein Expression, Vaccine Development, Biotech R&D, and Antigen Production Platforms
Official company contact disclosure, Investor-facing leadership disclosure, Biotech platform operating claim
ExpreS2ion is published because official and investor-facing company materials confirm current leadership, Horsholm operating address, and a real protein-expression biotech platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
ExpreS2ion Biotechnologies runs protein expression, vaccine platform development, and antigen production in Horsholm, Denmark.
- Lead
- Bent U. Frandsen (verified ↗)
- Address
- Agern Alle 1, 2970 Horsholm, Denmark (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Specialized biotech platform
- Capabilities
- Protein Expression · Vaccine Platform Development · Antigen Production
- Founded
- 2010
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Bent U. Frandsen
CEO
Full addressAgern Alle 1, 2970 Horsholm, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official ExpreS2ion contact page listing the Agern Alle 1 Horsholm address.
Open sourceSpecialized biotech platform
Horsholm, Denmark. Protein Expression, Vaccine Development, Biotech R&D, and Antigen Production Platforms. Review completed on 21 Mar 2026.
Danish corporate and biotech-development oversight
Official company contact disclosure, Investor-facing leadership disclosure, Biotech platform operating claim
Protein Expression, Vaccine Development, Biotech R&D, and Antigen Production Platforms
ExpreS2ion is published because official and investor-facing company materials confirm current leadership, Horsholm operating address, and a real protein-expression biotech platform.
Editorial note
ExpreS2ion is published because official and investor-facing company materials confirm current leadership, Horsholm operating address, and a real protein-expression biotech platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Protein Expression
Vaccine Platform Development
Antigen Production
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Protein-expression workflow
Vaccine-development systems
Biotech R&D infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is ExpreS2ion Biotechnologies located?
- ExpreS2ion Biotechnologies operates from Agern Alle 1, 2970 Horsholm, Denmark, Horsholm, Denmark.
- Who runs ExpreS2ion Biotechnologies?
- ExpreS2ion Biotechnologies is led by Bent U. Frandsen, CEO. Verified 21 Mar 2026.
- What does ExpreS2ion Biotechnologies do?
- ExpreS2ion Biotechnologies runs protein expression, vaccine platform development, and antigen production in Horsholm, Denmark. Core capabilities: Protein Expression, Vaccine Platform Development, Antigen Production.
Editorial context
Related technical briefs
Briefs that name Horsholm as a covered market or city.